PIMS-TS
Also written as: PIMS-TS — pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2
Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2, a severe post-infectious complication requiring intensive care management.
Full Definition
Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2, also known as multisystem inflammatory syndrome in children (MIS-C). This condition occurs weeks after SARS-CoV-2 infection and presents with fever, inflammation, and dysfunction of multiple organ systems including cardiovascular, gastrointestinal, neurologic, and dermatologic systems. Diagnostic criteria include fever, laboratory evidence of inflammation, multisystem involvement, and evidence of SARS-CoV-2 exposure or infection. Treatment involves immunosuppressive therapy including IVIG and corticosteroids. Editorial review must verify proper acronym usage and distinguish from acute COVID-19 infection.
Usage
Usage note: PIMS-TS and MIS-C refer to the same condition; use consistently within documents.
In Context
- "The patient met criteria for PIMS-TS with cardiac involvement requiring ICU admission." — Pediatric intensive care unit note
- "PIMS-TS typically occurs 2-6 weeks after SARS-CoV-2 infection, often in children who were asymptomatic during acute infection." — Clinical practice guideline